Atomo Diagnostics is an Australian based technology company commercialising a range of integrated devices for use in capillary blood based collection and diagnostic procedures. Atomo’s core competencies are the development, design and launch of medical devices that provide the next generation in usability.

The first product to market in 2012 is an innovative device for use in lateral flow rapid test applications.

Atomo wins Commercialisation Australia Grant. – link to Media Release.

The Atomo Team

The Atomo team has been instrumental in the development and commercialisation of a number of successful disruptive medical devices across international healthcare markets.